These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6214153)

  • 1. [Physical dependence of dihydroetorphine in mice and monkeys (author's transl)].
    Huang M; Qin BY
    Zhongguo Yao Li Xue Bao; 1982 Jun; 3(2):81-4. PubMed ID: 6214153
    [No Abstract]   [Full Text] [Related]  

  • 2. Physical dependence produced by dihydroetorphine in mice.
    Tokuyama S; Nakamura F; Takahashi M; Kaneto H
    Biol Pharm Bull; 1994 Aug; 17(8):1056-9. PubMed ID: 7820107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analgesic and other CNS depressive effects of dihydroetorphine (author's transl)].
    Huang M; Qin BY
    Zhongguo Yao Li Xue Bao; 1982 Mar; 3(1):9-13. PubMed ID: 6211911
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppressive effects of dihydroetorphine, a potent narcotic analgesic, in dihydroetorphine-dependent mice.
    Wu WR; Zheng JW; Li N; Bai HQ; Zhang KR; Li Y
    Eur J Pharmacol; 1999 Feb; 366(2-3):261-9. PubMed ID: 10082208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influences of locus coeruleus lesions and reserpine treatment on opioid physical dependence in rats.
    Miao H; Qin BY
    Zhongguo Yao Li Xue Bao; 1995 Mar; 16(2):137-40. PubMed ID: 7597914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacodynamics and pharmacokinetics of dihydroetorphine hydrochloride administered sublingually in mice and rats].
    Huang M; Wang MY; Yuan SL; Qin BY
    Zhongguo Yao Li Xue Bao; 1988 Jul; 9(4):308-12. PubMed ID: 3195339
    [No Abstract]   [Full Text] [Related]  

  • 7. Potent reinforcing effects of dihydroetorphine in rats.
    Martin TJ; Kim SA; Harris LS; Smith JE
    Eur J Pharmacol; 1997 Apr; 324(2-3):141-5. PubMed ID: 9145764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of etorphine levels in tissues of opiate tolerant and nontolerant rats.
    Tavani A; Luini A; Manara L
    J Pharmacol Exp Ther; 1979 Oct; 211(1):140-4. PubMed ID: 573787
    [No Abstract]   [Full Text] [Related]  

  • 9. Dihydroetorphine: physical dependence and stereotypy after continuous infusion in the rat.
    Aceto MD; Scates SM; Harris LS; Ji Z
    Eur J Pharmacol; 2000 Jan; 387(1):31-7. PubMed ID: 10633157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychic dependent potential of dihydroetorphine.
    Zheng J; Wang W; Chen J; Xie L; Wang G; Ha Y; Wang G; Ren Y; Zhang K; Cai Z
    J Toxicol Sci; 1998 Jul; 23 Suppl 2():292. PubMed ID: 9760488
    [No Abstract]   [Full Text] [Related]  

  • 11. Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration.
    Gmerek DE; Dykstra LA; Woods JH
    J Pharmacol Exp Ther; 1987 Aug; 242(2):428-36. PubMed ID: 3302208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation in nonhuman primates: evaluation of the physical dependence capacities of oripavine-thebaine partial agonists in patas monkeys.
    Cowan A
    Adv Biochem Psychopharmacol; 1973; 8(0):427-38. PubMed ID: 4211992
    [No Abstract]   [Full Text] [Related]  

  • 13. Etorphine in man. I. Subjective effects and suppression of morphine abstinence.
    Jasinski DR; Griffith JD; Carr CB
    Clin Pharmacol Ther; 1975 Mar; 17(3):267-72. PubMed ID: 1091396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug dependence potential of 1-(m-methoxyphenyl)-2-dimethylaminomethyl)-cyclohexan-1-ol hydrochloride (tramadol) tested in monkeys.
    Yanagita T
    Arzneimittelforschung; 1978; 28(1a):158-63. PubMed ID: 415747
    [No Abstract]   [Full Text] [Related]  

  • 15. The preclinical testing of drugs for opiate-like dependence-producing properties.
    Hill RC; Roemer D; Buescher HH
    Pharmacol Ther B; 1979; 5(1-3):505-9. PubMed ID: 40264
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of intragastric agmatine on morphine-induced physiological dependence in beagle dogs and rhesus monkeys.
    Su RB; Lu XQ; Huang Y; Liu Y; Gong ZH; Wei XL; Wu N; Li J
    Eur J Pharmacol; 2008 Jun; 587(1-3):155-62. PubMed ID: 18455724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study on development of physical dependence on alcohol and cross physical dependence liability of diazepam and barbital to alcohol in rhesus monkeys (author's transl)].
    Miyasato K
    Seishin Shinkeigaku Zasshi; 1978 Dec; 80(12):657-67. PubMed ID: 108696
    [No Abstract]   [Full Text] [Related]  

  • 18. [No physical dependence of skimmianine in mice, rats and monkeys].
    Chang ZQ; Wang SL; Liu F; Zhu MY; Tang XC
    Zhongguo Yao Li Xue Bao; 1982 Dec; 3(4):223-6. PubMed ID: 6219535
    [No Abstract]   [Full Text] [Related]  

  • 19. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very long-acting narcotic antagonists: the 14 beta-p-substituted cinnamoylaminomorphinones and their partial mu agonist codeinone relatives.
    Aceto MD; Bowman ER; May EL; Harris LS; Woods JH; Smith CB; Medzihradsky F; Jacobson AE
    Arzneimittelforschung; 1989 May; 39(5):570-5. PubMed ID: 2547389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.